Stocks · Health care · Services-Commercial Physical & Biological Research

Charles River Laboratories

CRL Clue Score34
United States Fiscal year ends December CIK 0001100682 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Glenn Coleman
30 Sep 2026
EVP & Chief Financial Officer
Buy
10
$297.43
$2.97K
Joseph W LaPlume
3 Mar 2026
EVP, Corp Strategy & Develop
Buy
25
$174.54
$4.36K

What was left out

Form 4 filings counted 59
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 19
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 702,199
History held since 5 Oct 2006